Chmielewska 2011 Pharmacol Rep: Revision history

12 August 2013

• curprev 15:3315:33, 12 August 2013‎ Bidaurratzaga Eider talk contribs‎ 2,002 bytes 0‎ No edit summary
• curprev 13:1613:16, 12 August 2013‎ Bidaurratzaga Eider talk contribs‎ 2,002 bytes +8‎ No edit summary

7 August 2013

• curprev 14:3914:39, 7 August 2013‎ Bidaurratzaga Eider talk contribs‎ 1,994 bytes −18‎ No edit summary

6 August 2013

• curprev 16:0816:08, 6 August 2013‎ Gnaiger Erich talk contribs‎ 2,012 bytes 0‎ No edit summary

5 April 2012

• curprev 03:1803:18, 5 April 2012‎ Gnaiger Erich talk contribs‎ 2,012 bytes 0‎ No edit summary

19 December 2011

• curprev 23:0023:00, 19 December 2011‎ Gnaiger Erich talk contribs‎ 2,012 bytes −2‎ No edit summary

8 December 2011

• curprev 11:5711:57, 8 December 2011‎ Harrison DK talk contribs‎ m 2,014 bytes 0‎ moved Chmielewska 2011 Pharmacol. Rep. to Chmielewska 2011 Pharmacol Rep
• curprev 11:5711:57, 8 December 2011‎ Harrison DK talk contribs‎ 2,014 bytes −2‎ No edit summary

16 November 2011

• curprev 16:2016:20, 16 November 2011‎ Harrison DK talk contribs‎ m 2,016 bytes 0‎ moved Chmielewska 2011 PharmacolRep to Chmielewska 2011 Pharmacol. Rep.

23 October 2011

• curprev 11:4211:42, 23 October 2011‎ Gnaiger Erich talk contribs‎ 2,016 bytes +5‎ No edit summary
• curprev 11:4111:41, 23 October 2011‎ Gnaiger Erich talk contribs‎ 2,011 bytes −2‎ No edit summary

5 September 2011

• curprev 13:4513:45, 5 September 2011‎ Wiethuechter Anita talk contribs‎ 2,013 bytes +96‎ No edit summary

1 September 2011

• curprev 09:1709:17, 1 September 2011‎ FriedenGagl Judith talk contribs‎ 1,917 bytes +1,917‎ Created page with "{{Publication |title=Chmielewska L, Malińska D (2011) Cytoprotective action of the potassium channel opener NS1619 under conditions of disrupted calcium homeostasis. Pharmacol. ..."